Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
Conditions: Ewing Sarcoma; Rhabdomyosarcoma; Synovial Sarcoma Interventions: Biological: Peptide vaccine IPX Sponsors: University Hospital Tuebingen; Deutsches Konsortium f ürTranslationale Krebsforschung (DKTK); Cooperative Ewing Sarkom Studiengruppe; Cooperative Weichteilsarkom Study Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Ewing's Sarcoma | Hospitals | Research | Rhabdomyosarcoma | Sarcomas | Study | Synovial Sarcoma | Vaccines